MarketWatch/Business Wire, 07/12/2012
RESEARCH TRIANGLE PARK, N.C., Jul 12, 2012 (BUSINESS WIRE) — To help biopharmaceutical companies enter the rapidly growing Brazilian biopharmaceutical market, Quintiles today announced the opening of its Global Commercial Solutions business in Brazil, offering customized sales forces, market penetration strategies and product solutions.
The move into Brazil is part of Quintiles’ strategy to help biopharma companies expand into growing emerging markets while managing costs and risk. Quintiles recently announced Global Commercial Solutions expansion into Russia, and the Middle East and North Africa (MENA) region. Brazil is the world’s fifth most populous country, with a population of about 205 million and a biopharmaceutical market valued at $17.1 billion.
Leading the business in Brazil will be General Manager Vera Valente, based in Quintiles’ offices in Sao Paulo. Most recently, Valente was a director at Interfarma (the Brazilian Pharmaceutical Research Companies Association), where she was responsible for both the Innovation Program and the Market Access Group.